Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 1.00 |
| ▸ | SOAT1 | P35610 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.89 |
| ▸ | CNR1 | P21554 | 1/20 | 0.78 |
| ▸ | TERT | O14746 | 3/20 | 0.70 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.70 |
| ▸ | PPARG | P37231 | 3/20 | 0.70 |
| ▸ | PPARD | Q03181 | 3/20 | 0.70 |
| ▸ | PPARA | Q07869 | 3/20 | 0.70 |
| ▸ | MAPT | P10636 | 2/20 | 0.70 |
| ▸ | BLM | P54132 | 2/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.70 |
| ▸ | FABP4 | P15090 | 2/20 | 0.70 |
| ▸ | GMNN | O75496 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11846101 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| Oleamide SCHEMBL195221 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL21983255 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL23528231 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL10445392 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL24340776 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL21501560 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL21654359 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL22419041 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A | |
| SCHEMBL15127 | 1.00 | FAAH (1.00) | FAAHSOAT1CYP1A2CYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062580-A1 | REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT | THE PILOT INK CO., LTD. (JP) | 2026-03-05 | — | — | US | disclosed |
| US-12460099-B2 | Reversibly thermochromic composition, reversibly thermochromic microcapsule pigment encapsulating reversibly thermochromic composition, and writing instrument using reversibly thermochromic microcapsule pigment | THE PILOT INK CO., LTD. (JP) | 2025-11-04 | — | — | US | disclosed |
| CN-115427498-B | Resin composition for sliding element and sliding element | 奥依列斯工业株式会社 | 2025-03-11 | — | — | CN | disclosed |
| EP-3608386-B1 | REVERSIBLY THERMOCHROMIC COMPOSITION, AND REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT HAVING SAME ENCLOSED THEREIN | PILOT INK CO LTD (JP) | 2025-02-19 | — | — | EP | disclosed |
| CN-119463010-A | Pellets, molded article, and method for producing molded article | 旭化成株式会社 | 2025-02-18 | — | — | CN | disclosed |
| US-12123107-B2 | Reversibly thermochromic composite fiber | KABUSHIKI KAISHA PILOT CORPORATION (JP) | 2024-10-22 | — | — | US | disclosed |
| WO-2023176838-A1 | COMPOSITION CONTAINING TREATMENT AGENT FOR ACRYLIC SYNTHETIC FIBERS, METHOD FOR PREPARING DILUTION OF TREATMENT AGENT FOR ACRYLIC SYNTHETIC FIBERS, METHOD FOR TREATING ACRYLIC SYNTHETIC FIBERS, AND ACRYLIC SYNTHETIC FIBERS | 竹本油脂株式会社 | 2023-09-21 | — | — | WO | disclosed |
| WO-2023085082-A1 | RESIN ADDITIVE MASTERBATCH, SYNTHETIC RESIN COMPOSITION, AND MOLDED OBJECT | 株式会社ADEKA | 2023-05-19 | — | — | WO | disclosed |
| US-20220169919-A1 | REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT | THE PILOT INK CO., LTD. (JP) | 2022-06-02 | — | — | US | disclosed |
| EP-3950068-A1 | REVERSIBLE THERMOCHROMIC COMPOSITION, REVERSIBLE THERMOCHROMIC MICROCAPSULE PIGMENT COMPRISING SAME, AND WRITING INSTRUMENT USING SAME | THE PILOT INK CO., LTD. (JP) | 2022-02-09 | — | — | EP | disclosed |
| CN-106433634-B | A kind of preparation method of monodisperse pulmbous sulfide quantum dot | 武汉华思创新科技有限公司 | 2018-10-12 | — | — | CN | disclosed |
| CN-108067232-A | The catalysis material CoNiO of high activity OER and ORR2And its synthetic method | 天津大学 | 2018-05-25 | — | — | CN | disclosed |
| EP-1039902-A4 | INHIBITORS OF GAP JUNCTION COMMUNICATION | SCRIPPS RESEARCH INST (US) | 2002-07-17 | — | — | EP | disclosed |
| EP-1039902-A2 | INHIBITORS OF GAP JUNCTION COMMUNICATION | The Scripps Research Institute (US) | 2000-10-04 | — | — | EP | disclosed |
| WO-1999026584-A2 | INHIBITORS OF GAP JUNCTION COMMUNICATION | THE SCRIPPS RESEARCH INSTITUTE (US) | 1999-06-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062580-A1 | REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT | TYR, SCO2, HBB | FAAH 4333/4885SOAT1 2226/4885CYP1A2 696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.